Dudediligence.

Elanco Animal Health Incorporated

ELANNYSE · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.03BSep ’24$1.02BDec ’24$1.19BMar ’25$1.24BJun ’25$1.14BSep ’25$1.14BDec ’25$1.37BMar ’26$1.37BJun ’26
Net income, by quarter
$364.0MSep ’24−$8.0MDec ’24$67.0MMar ’25$11.0MJun ’25−$34.0MSep ’25−$276.0MDec ’25$57.0MMar ’26$54.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$4.76B$4.41B$4.42B$4.44B$4.71B
Gross profit$2.63B$2.50B$2.49B$2.44B$2.59B
Net income−$483.0M−$78.0M−$1.23B$338.0M−$232.0M
Operating cash flow$483.0M$452.0M$271.0M$541.0M$560.0M
Free cash flow$324.0M$281.0M$131.0M$394.0M$284.0M
Cash$638.0M$345.0M$352.0M$468.0M$545.0M
Debt$6.32B$5.84B$5.77B$4.32B$3.84B
Shares outstanding473.1M474.2M492.8M494.4M497.0M